In this study, we found that MES treatment modulates Methanobrevibacter, reprograms colon gene expression profiles associated with cytokine–cytokine receptor interaction, and alters frequencies of intestinal CD11b+ myeloid cells and CD3+ T cells in DSS-induced colitis in piglets. The gene discussed is ITGAM; the disease is colitis.